drugset / Trial / NCT01816997

The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose

NCT01816997

Phase 4 Unknown 160 enrolled Taipei Veterans General Hospital, Taiwan
RandomizedParallel-groupOpen-labelHealth-services research

Summary

Evaluate the effects of rosuvastatin (maybe the highest diabetogenic) and pravastatin (seems to be protective) on the glucose homeostasis and other biomarkers in subjects with impaired fasting glucose.

Timeline

Start
2012-01
Primary completion
2017-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pravastatin Small molecule 40 mg
Subject Rosuvastatin Small molecule 10 mg

Indications